Clinical trial NCT04361721 - References

Chronic Migraine — Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine

Citation(s)

•   Andersen HH, Duroux M, Gazerani P
  Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods. Mol Neurobiol. 2016 Apr;53(3):1494-1500. doi: 10.1007/s12035-015-9106-5. Epub 2015 Feb 1.
•   Apolone G, Mosconi P
  The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36.
•   Ashina M, Tepper S, Brandes JL, Reuter U, Boudreau G, Dolezil D, Cheng S, Zhang F, Lenz R, Klatt J, Mikol DD
  Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study. Cephalalgia. 2018 Sep;38(10):1611-1621. doi: 10.1177/0333102418788347. Epub 2018 Jul 8.
•   Bagby RM, Parker JDA, Taylor GJ
  Twenty-five years with the 20-item Toronto Alexithymia Scale. J Psychosom Res. 2020 Jan 23;131:109940. doi: 10.1016/j.jpsychores.2020.109940. [Epub ahead of print] Review.
•   Bjelland I, Dahl AA, Haug TT, Neckelmann D
  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. Review.
•   Bottiroli S, Galli F, Viana M, Sances G, Tassorelli C
  Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse. Front Psychol. 2018 May 14;9:704. doi: 10.3389/fpsyg.2018.00704. eCollection 2018.
•   Charles A, Pozo-Rosich P
  Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet. 2019 Nov 9;394(10210):1765-1774. doi: 10.1016/S0140-6736(19)32504-8. Epub 2019 Oct 23. Review.
•   Coppola G, Di Lorenzo C, Schoenen J, Pierelli F
  Habituation and sensitization in primary headaches. J Headache Pain. 2013 Jul 30;14:65. doi: 10.1186/1129-2377-14-65. Review.
•   De Icco R, Perrotta A, Grillo V, Cosentino G, Sances G, Sandrini G, Tassorelli C
  Experimentally induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study. Pain. 2020 Feb;161(2):429-438. doi: 10.1097/j.pain.0000000000001726.
•   Demartini C, Greco R, Zanaboni AM, Sances G, De Icco R, Borsook D, Tassorelli C
  Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back. Prog Neurobiol. 2019 Jun;177:15-32. doi: 10.1016/j.pneurobio.2019.02.002. Epub 2019 Feb 13. Review.
•   Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
  Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202.
•   Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L
  Development and validation of the Migraine-Specific Quality of Life Questionnaire. Headache. 1998 Apr;38(4):295-302.
•   Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S
  A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003 Dec;12(8):963-74.
•   Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF; American Migraine Prevalence Prevention Advisory Group
  Cutaneous allodynia in the migraine population. Ann Neurol. 2008 Feb;63(2):148-58.
•   Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C
  Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction. 1994 May;89(5):563-72.
•   Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Willer JC
  The lower limb flexion reflex in humans. Prog Neurobiol. 2005 Dec;77(6):353-95. Epub 2005 Dec 28. Review.
•   Scalone L, Cortesi PA, Mantovani LG, Ciampichini R, Cesana G
  Reference Eq-5d-3l and Eq-5d-5l Data From the Italian General Population. Value Health. 2014 Nov;17(7):A514-5. doi: 10.1016/j.jval.2014.08.1591. Epub 2014 Oct 26.
•   Schmittgen TD, Livak KJ
  Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101-8.
•   Stewart WF, Lipton RB, Dowson AJ, Sawyer J
  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-8. Review.
•   Tepper SJ, Diener HC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD
  Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology. 2019 May 14;92(20):e2309-e2320. doi: 10.1212/WNL.0000000000007497. Epub 2019 Apr 17.

Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine: an Open Label, Hypothesis Generator Study

Details for clinical trial NCT04361721